Organisation paid for research Program year 2025 Source: CMS Open Payments

Vilo Research Group, Inc

Neither a doctor nor a teaching hospital

Research payments

$426,577

125 payments

Through program year 2025, Vilo Research Group, Inc is reported as receiving $426,577 in research payments, across 125 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$11,428	1
2023	Research	$27,293	4
2022	Research	$1,056	2
2021	Research	$2,678	1
2019	Research	$384,123	117

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $384,123 117 payments
Novartis Pharmaceuticals Corporation $37,417 3 payments
AstraZeneca Pharmaceuticals LP $5,037 5 payments

Studies the money was for Research payments · program years 2019–2025

M16-067 $133,000 29 payments
M14-675 $106,224 24 payments
M16-006 $71,607 16 payments
A Randomized, Controlled, Multicenter, Open-Label Trial Comparing A Post-Discharge Care Pathway Involving Aggressive LDL-C Management With Inclisiran With Usual Care in Patients With A Recent Acute Coronary Syndrome $37,417 3 payments
M16-066 $23,275 11 payments
M15-991 $17,928 4 payments
M16-000 $14,110 28 payments
M14-234 $9,978 3 payments
M14-533 $8,000 2 payments
A 54 Week Treatment, Multicenter, Randomized, Double Blind, Double Dummy, Placebo and Active Controlled, Parallel Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis $3,819 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.